Adaptive Biotechnologies (NASDAQ:ADPT) Releases Earnings Results, Meets Expectations
Adaptive Biotechnologies (NASDAQ:ADPT – Get Free Report) issued its quarterly earnings data on Wednesday. The company reported ($0.33) earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of ($0.33), Briefing.com reports. The firm had revenue of $48.93 million during the quarter, compared to the consensus estimate of $44.87 million. Adaptive Biotechnologies had a […]